These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modeling the risk of an emerging pathogen entering the Canadian blood supply. Kleinman S; Cameron C; Custer B; Busch M; Katz L; Kralj B; Matheson I; Murphy K; Preiksaitis J; Devine D Transfusion; 2010 Dec; 50(12):2592-606. PubMed ID: 20553433 [TBL] [Abstract][Full Text] [Related]
3. Risks of transfusion. Squires JE South Med J; 2011 Nov; 104(11):762-9. PubMed ID: 22024787 [TBL] [Abstract][Full Text] [Related]
4. [Blood safety in Mexico. Achievements and challenges]. Sánchez-Guerrero SA Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294 [No Abstract] [Full Text] [Related]
5. Intraoperative factors and the risk of respiratory complications after pneumonectomy. Blank RS; Hucklenbruch C; Gurka KK; Scalzo DC; Wang XQ; Jones DR; Tanner SR; Jaeger JM Ann Thorac Surg; 2011 Oct; 92(4):1188-94. PubMed ID: 21958762 [TBL] [Abstract][Full Text] [Related]
6. [Respiratory complications after transfusion]. Bernasinski M; Mertes PM; Carlier M; Dupont H; Girard M; Gette S; Just B; Malinovsky JM Transfus Clin Biol; 2014 May; 21(2):60-5. PubMed ID: 24814817 [TBL] [Abstract][Full Text] [Related]
7. [Techniques of preparation and indications of labile blood products]. Clément S Transfus Clin Biol; 2011 Apr; 18(2):250-61. PubMed ID: 21474355 [TBL] [Abstract][Full Text] [Related]
9. The hazards of blood transfusion. Marik PE Br J Hosp Med (Lond); 2009 Jan; 70(1):12-5. PubMed ID: 19357571 [TBL] [Abstract][Full Text] [Related]
10. [Universal implementation of pathogen inactivation in labile blood products is a major step towards transfusion safety]. Cazenave JP Bull Acad Natl Med; 2010 Dec; 194(9):1707-19; discussion 1719-20. PubMed ID: 22043595 [TBL] [Abstract][Full Text] [Related]
11. [Blood transfusion and infectious diseases]. Hamaguchi I Rinsho Byori; 2013 May; 61(5):414-7. PubMed ID: 23947180 [TBL] [Abstract][Full Text] [Related]
12. Alloexposed blood donors and transfusion-related acute lung injury: a case-referent study. Middelburg RA; van Stein D; Atsma F; Wiersum-Osselton JC; Porcelijn L; Beckers EA; Briët E; van der Bom JG Transfusion; 2011 Oct; 51(10):2111-7. PubMed ID: 21985044 [TBL] [Abstract][Full Text] [Related]
13. Efforts Toward Elimination of Infectious Agents in Blood Products. Jacquot C; Delaney M J Intensive Care Med; 2018 Oct; 33(10):543-550. PubMed ID: 29562814 [TBL] [Abstract][Full Text] [Related]
14. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Vlaar AP; Binnekade JM; Prins D; van Stein D; Hofstra JJ; Schultz MJ; Juffermans NP Crit Care Med; 2010 Mar; 38(3):771-8. PubMed ID: 20035217 [TBL] [Abstract][Full Text] [Related]
15. Blood transfusion safety: the potential role of the patient. Davis RE; Vincent CA; Murphy MF Transfus Med Rev; 2011 Jan; 25(1):12-23. PubMed ID: 21134623 [TBL] [Abstract][Full Text] [Related]
16. Intraoperative transfusion-related acute lung injury in a child during calvarial vault remodeling. Schleicherk K; Muzaffar A; Tobias JD J Craniofac Surg; 2011 Jan; 22(1):194-8. PubMed ID: 21233752 [TBL] [Abstract][Full Text] [Related]
17. Transfusion medicine illustrated. Systemic neutrophilic aggregates in transfusion-related acute lung injury. Lima J; Reddy VV; Marques MB Transfusion; 2010 Jul; 50(7):1427-8. PubMed ID: 20636530 [No Abstract] [Full Text] [Related]